
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.1B | $2.3B | $2B | $1.9B | $1.9B | |
Revenue Growth (YoY) | -8.35% | 8.76% | -10.52% | -3.35% | -0.83% | |
Cost of Revenues | $1.4B | $1.5B | $1.2B | $1.1B | $950.3M | |
Gross Profit | $688M | $781.9M | $795.2M | $863M | $983M | |
Gross Profit Margin | 33.2% | 34.69% | 39.43% | 44.27% | 50.85% | |
R&D Expenses | $132.5M | $151.8M | $187.6M | $242.3M | $279.3M | |
Selling, General & Admin | $446.7M | $478.3M | $583.3M | $543.5M | $552.2M | |
Other Inc / (Exp) | -$150K | -$1.8M | $19.7M | -$7.6M | -$3.5M | |
Operating Expenses | $579.2M | $630.1M | $770.9M | $785.8M | $831.6M | |
Operating Income | $108.8M | $151.9M | $24.3M | $77.2M | $151.4M | |
Net Interest Expenses | $1.8M | -- | $1.9M | -- | -- | |
EBT. Incl. Unusual Items | $106.9M | $153.8M | $42.1M | $74.7M | $154.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $32.2M | $16.2M | $31.2M | $20.1M | $39.8M | |
Net Income to Company | $74.7M | $137.6M | $10.9M | $54.6M | $114.7M | |
Minority Interest in Earnings | -$3M | -$3.2M | -$1.9M | -$1.4M | -$3.1M | |
Net Income to Common Excl Extra Items | $71.7M | $134.5M | $9M | $53.3M | $111.6M | |
Basic EPS (Cont. Ops) | $1.18 | $2.21 | $0.15 | $0.95 | $2.04 | |
Diluted EPS (Cont. Ops) | $1.16 | $2.09 | $0.14 | $0.88 | $1.90 | |
Weighted Average Basic Share | $60.9M | $60.7M | $60M | $56.2M | $54.8M | |
Weighted Average Diluted Share | $61.8M | $64.2M | $62.8M | $60.2M | $58.6M | |
EBITDA | $215.9M | $247M | $199M | $154.6M | $245.8M | |
EBIT | $109.3M | $156.1M | $48.8M | $82.3M | $158.1M | |
Revenue (Reported) | $2.1B | $2.3B | $2B | $1.9B | $1.9B | |
Operating Income (Reported) | $108.8M | $151.9M | $24.3M | $77.2M | $151.4M | |
Operating Income (Adjusted) | $109.3M | $156.1M | $48.8M | $82.3M | $158.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $541.1M | $510.6M | $445M | $450.1M | $451.4M | |
Revenue Growth (YoY) | 7.49% | -5.64% | -12.84% | 1.13% | 0.31% | |
Cost of Revenues | $362.4M | $326.5M | $263.5M | $232.8M | $214.5M | |
Gross Profit | $178.7M | $184M | $181.5M | $217.2M | $237M | |
Gross Profit Margin | 33.03% | 36.04% | 40.79% | 48.27% | 52.49% | |
R&D Expenses | $31.7M | $34M | $63.6M | $66.9M | $60.7M | |
Selling, General & Admin | $112.8M | $122.3M | $141.4M | $140M | $128.1M | |
Other Inc / (Exp) | -$798K | $4.5M | -$1.9M | $879K | $1.1M | |
Operating Expenses | $144.5M | $156.4M | $205M | $206.9M | $188.8M | |
Operating Income | $34.2M | $27.7M | -$23.5M | $10.4M | $48.2M | |
Net Interest Expenses | -- | $433K | -- | -- | -- | |
EBT. Incl. Unusual Items | $33.5M | $31.7M | -$16.7M | $11.5M | $50.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $10.1M | $10.4M | -$4.6M | $3M | $10.5M | |
Net Income to Company | $23.5M | $21.3M | -$12.1M | $8.6M | $40M | |
Minority Interest in Earnings | -$1M | -$691K | $262K | -$1.3M | -$2.1M | |
Net Income to Common Excl Extra Items | $22.4M | $20.6M | -$11.8M | $7.2M | $37.9M | |
Basic EPS (Cont. Ops) | $0.37 | $0.34 | -$0.21 | $0.13 | $0.70 | |
Diluted EPS (Cont. Ops) | $0.35 | $0.32 | -$0.21 | $0.12 | $0.66 | |
Weighted Average Basic Share | $60.7M | $60.7M | $56.3M | $55.1M | $54M | |
Weighted Average Diluted Share | $64.1M | $63.6M | $56.3M | $59.3M | $57.2M | |
EBITDA | $51.1M | $58.9M | $11.8M | $39M | $74.5M | |
EBIT | $33.9M | $32.2M | -$15.5M | $13.7M | $50.9M | |
Revenue (Reported) | $541.1M | $510.6M | $445M | $450.1M | $451.4M | |
Operating Income (Reported) | $34.2M | $27.7M | -$23.5M | $10.4M | $48.2M | |
Operating Income (Adjusted) | $33.9M | $32.2M | -$15.5M | $13.7M | $50.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.1B | $2.2B | $2B | $2B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4B | $1.4B | $1.2B | $1.1B | $931.9M | |
Gross Profit | $694.5M | $787.3M | $792.7M | $898.8M | $1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $126.7M | $154.1M | $217.2M | $245.6M | $273.2M | |
Selling, General & Admin | $448.6M | $487.8M | $602.4M | $542.1M | $540.3M | |
Other Inc / (Exp) | -$687K | $3.5M | $13.2M | -$4.7M | -$3.3M | |
Operating Expenses | $575.3M | $642M | $819.6M | $787.7M | $813.5M | |
Operating Income | $119.2M | $145.3M | -$26.9M | $111.1M | $189.2M | |
Net Interest Expenses | $1.6M | -- | -- | $3.4M | -- | |
EBT. Incl. Unusual Items | $116.9M | $152M | -$6.3M | $102.9M | $193.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $35.2M | $16.5M | $16.2M | $27.6M | $47.3M | |
Net Income to Company | $81.7M | $135.5M | -$22.5M | $75.3M | $146.2M | |
Minority Interest in Earnings | -$3.1M | -$2.8M | -$970K | -$3M | -$3.9M | |
Net Income to Common Excl Extra Items | $78.6M | $132.6M | -$23.4M | $72.3M | $142.3M | |
Basic EPS (Cont. Ops) | $1.30 | $2.19 | -$0.40 | $1.29 | $2.60 | |
Diluted EPS (Cont. Ops) | $1.26 | $2.07 | -$0.42 | $1.21 | $2.46 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $216.3M | $254.7M | $152M | $181.8M | $281.4M | |
EBIT | $119.5M | $154.4M | $1M | $111.5M | $195.3M | |
Revenue (Reported) | $2.1B | $2.2B | $2B | $2B | $1.9B | |
Operating Income (Reported) | $119.2M | $145.3M | -$26.9M | $111.1M | $189.2M | |
Operating Income (Adjusted) | $119.5M | $154.4M | $1M | $111.5M | $195.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $541.1M | $510.6M | $445M | $450.1M | $451.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $362.4M | $326.5M | $263.5M | $232.8M | $214.5M | |
Gross Profit | $178.7M | $184M | $181.5M | $217.2M | $237M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $31.7M | $34M | $63.6M | $66.9M | $60.7M | |
Selling, General & Admin | $112.8M | $122.3M | $141.4M | $140M | $128.1M | |
Other Inc / (Exp) | -$798K | $4.5M | -$1.9M | $879K | $1.1M | |
Operating Expenses | $144.5M | $156.4M | $205M | $206.9M | $188.8M | |
Operating Income | $34.2M | $27.7M | -$23.5M | $10.4M | $48.2M | |
Net Interest Expenses | -- | $433K | -- | -- | -- | |
EBT. Incl. Unusual Items | $33.5M | $31.7M | -$16.7M | $11.5M | $50.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $10.1M | $10.4M | -$4.6M | $3M | $10.5M | |
Net Income to Company | $23.5M | $21.3M | -$12.1M | $8.6M | $40M | |
Minority Interest in Earnings | -$1M | -$691K | $262K | -$1.3M | -$2.1M | |
Net Income to Common Excl Extra Items | $22.4M | $20.6M | -$11.8M | $7.2M | $37.9M | |
Basic EPS (Cont. Ops) | $0.37 | $0.34 | -$0.21 | $0.13 | $0.70 | |
Diluted EPS (Cont. Ops) | $0.35 | $0.32 | -$0.21 | $0.12 | $0.66 | |
Weighted Average Basic Share | $60.7M | $60.7M | $56.3M | $55.1M | $54M | |
Weighted Average Diluted Share | $64.1M | $63.6M | $56.3M | $59.3M | $57.2M | |
EBITDA | $51.1M | $58.9M | $11.8M | $39M | $74.5M | |
EBIT | $33.9M | $32.2M | -$15.5M | $13.7M | $50.9M | |
Revenue (Reported) | $541.1M | $510.6M | $445M | $450.1M | $451.4M | |
Operating Income (Reported) | $34.2M | $27.7M | -$23.5M | $10.4M | $48.2M | |
Operating Income (Adjusted) | $33.9M | $32.2M | -$15.5M | $13.7M | $50.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $488M | $515.5M | $348.2M | $336.3M | $290.7M | |
Short Term Investments | -- | $50.3M | $25.1M | $6M | $26.2M | |
Accounts Receivable, Net | $474.1M | $582M | $708.9M | $775.6M | $800.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $15.4M | $24.9M | $37M | $40.4M | $40.6M | |
Other Current Assets | -- | -- | $8.1M | $7.9M | $10.1M | |
Total Current Assets | $1.1B | $1.3B | $1.3B | $1.3B | $1.2B | |
Property Plant And Equipment | $303.5M | $260.2M | $233.4M | $239M | $206.7M | |
Long-Term Investments | $59.9M | $11.4M | $5.9M | $21.9M | $19.9M | |
Goodwill | $325.8M | $329.7M | $515.1M | $524.2M | $515.2M | |
Other Intangibles | $79.7M | $82.6M | $176M | $180.9M | $158.4M | |
Other Long-Term Assets | -- | -- | $125.8M | $60.7M | $61.2M | |
Total Assets | $1.9B | $2B | $2.3B | $2.4B | $2.3B | |
Accounts Payable | $367M | $430.2M | $742.9M | $838.5M | $802.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $48.4M | $34.1M | $31M | $35.4M | $25.8M | |
Other Current Liabilities | $19.6M | $21.1M | $105.3M | $77.8M | $37.2M | |
Total Current Liabilities | $600.3M | $672.5M | $1.1B | $1.1B | $1B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $700.7M | $785.3M | $1.3B | $1.3B | $1.2B | |
Common Stock | $2.2M | $2.1M | $2.1M | $2M | $1.9M | |
Other Common Equity Adj | $16M | -$40.3M | -$91.9M | -$85.3M | -$108.8M | |
Common Equity | $1.1B | $1.2B | $1B | $1.1B | $1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $35.5M | $35.2M | $33.1M | $31.8M | $31.9M | |
Total Equity | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
Total Liabilities and Equity | $1.9B | $2B | $2.3B | $2.4B | $2.3B | |
Cash and Short Terms | $488M | $565.8M | $373.3M | $342.3M | $316.9M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $520.1M | $589.3M | $305.7M | $266.9M | $285.9M | |
Short Term Investments | $17.6M | $31.4M | $21.2M | $11.2M | $27.3M | |
Accounts Receivable, Net | $416.9M | $479.6M | $545.8M | $610.7M | $647.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18.8M | $41.2M | $44.3M | $41.3M | $54.7M | |
Other Current Assets | -- | -- | $3M | $656K | $8.9M | |
Total Current Assets | $1.1B | $1.2B | $1.1B | $1.2B | $1.1B | |
Property Plant And Equipment | $264.3M | $239.9M | $254M | $223.6M | $206.4M | |
Long-Term Investments | $43.1M | $6.9M | $15.4M | $16.2M | $21.1M | |
Goodwill | $322.8M | $328.1M | $522.8M | $521.2M | $521.1M | |
Other Intangibles | $79.4M | $79.4M | $179.9M | $175.3M | $160.3M | |
Other Long-Term Assets | -- | -- | $50M | $60.2M | $60.7M | |
Total Assets | $1.8B | $1.9B | $2.2B | $2.2B | $2.1B | |
Accounts Payable | $347.2M | $374.6M | $602.2M | $629.6M | $639.8M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $44.5M | $31.4M | $33.3M | $31.8M | $25.6M | |
Other Current Liabilities | $3.9M | $23.1M | $133.7M | $83.6M | $38.2M | |
Total Current Liabilities | $557.1M | $612.5M | $992.9M | $995M | $886.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $638.9M | $712.8M | $1.1B | $1.1B | $1B | |
Common Stock | $2.2M | $2.2M | $2.1M | $2M | $1.9M | |
Other Common Equity Adj | -$17.8M | -$56.5M | -$85.4M | -$96.8M | -$92.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $34.1M | $34M | $32.6M | $31.1M | $35.6M | |
Total Equity | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | |
Total Liabilities and Equity | $1.8B | $1.9B | $2.2B | $2.2B | $2.1B | |
Cash and Short Terms | $537.6M | $620.7M | $326.8M | $278.1M | $313.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $74.7M | $137.6M | $10.9M | $54.6M | $114.7M | |
Depreciation & Amoritzation | $106.6M | $90.9M | $150.3M | $72.3M | $87.8M | |
Stock-Based Compensation | $28.8M | $44.5M | $65M | $97.2M | $106.6M | |
Change in Accounts Receivable | -$4M | -$135M | -$41.9M | -$56.3M | -$28.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $185.4M | $220.9M | $256M | $224.2M | $258.2M | |
Capital Expenditures | $67.3M | $55M | $63.8M | $116.1M | $78.1M | |
Cash Acquisitions | -$1.2M | -$10.4M | -$138M | -$6.8M | -$527K | |
Cash From Investing | -$101.1M | -$76.4M | -$166.1M | -$108.7M | -$97.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $153.2M | -- | $78.5M | -- | -- | |
Long-Term Debt Repaid | -$167.3M | -$1.2M | -$78.5M | -- | -- | |
Repurchase of Common Stock | -$43.7M | -$100M | -$135.7M | -$125.5M | -$224.6M | |
Other Financing Activities | -$1.7M | -$4M | $21.6M | -$23.7M | -$50.5M | |
Cash From Financing | -$57.7M | -$80.1M | -$113M | -$147.3M | -$270.5M | |
Beginning Cash (CF) | $418.8M | $488M | $515.5M | $448.2M | $411.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $26.5M | $64.4M | -$23.2M | -$31.7M | -$110.2M | |
Ending Cash (CF) | $488M | $515.5M | $448.2M | $411.3M | $290.9M | |
Levered Free Cash Flow | $118.1M | $165.9M | $192.2M | $108.1M | $180M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.5M | $21.3M | -$12.1M | $8.6M | $40M | |
Depreciation & Amoritzation | $17.2M | $26.6M | $27.3M | $25.2M | $23.6M | |
Stock-Based Compensation | $7.2M | $9.5M | $25.2M | $27.3M | $17.1M | |
Change in Accounts Receivable | $47.2M | $92.7M | $164.1M | $158.1M | $163.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $77.4M | $74.9M | $42M | $14M | $62.3M | |
Capital Expenditures | $12M | $10.9M | $37.2M | $13.8M | $17.1M | |
Cash Acquisitions | -- | -- | -$6.5M | -$527K | -- | |
Cash From Investing | -$17M | $16.9M | -$36.1M | -$13.9M | -$17.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $78.5M | -- | -- | -- | |
Long-Term Debt Repaid | -$182K | -$78.5M | -- | -- | -- | |
Repurchase of Common Stock | -$4.9M | -$8.3M | -$51M | -$62.1M | -$56.2M | |
Other Financing Activities | -$378K | $6.7M | -$22.5M | -$432K | -$471K | |
Cash From Financing | -$3.4M | -$1.4M | -$72.2M | -$62.2M | -$54.8M | |
Beginning Cash (CF) | $488M | $515.5M | $448.2M | $411.3M | $290.9M | |
Foreign Exchange Rate Adjustment | -$24.9M | -$16.7M | -$1.2M | -$7.3M | $5.2M | |
Additions / Reductions | $56.9M | $90.5M | -$66.4M | -$62.1M | -$10M | |
Ending Cash (CF) | $520.1M | $589.3M | $380.7M | $341.9M | $286.2M | |
Levered Free Cash Flow | $65.4M | $64.1M | $4.8M | $173K | $45.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $81.7M | $135.5M | -$22.5M | $75.3M | $146.2M | |
Depreciation & Amoritzation | $96.8M | $100.3M | $151M | $70.3M | $86.1M | |
Stock-Based Compensation | $27.5M | $46.8M | $80.7M | $99.3M | $96.5M | |
Change in Accounts Receivable | -$56.1M | -$89.4M | $29.5M | -$62.4M | -$22.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $206M | $218.5M | $223M | $196.3M | $306.5M | |
Capital Expenditures | $68M | $53.9M | $90.2M | $92.8M | $81.4M | |
Cash Acquisitions | -$1.2M | -$10.4M | -$144.5M | -$852K | -- | |
Cash From Investing | -$107.3M | -$42.4M | -$219.1M | -$86.5M | -$101.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $153.2M | $78.5M | -- | -- | -- | |
Long-Term Debt Repaid | -$167.4M | -$79.6M | -- | -- | -- | |
Repurchase of Common Stock | -$30.3M | -$103.4M | -$178.4M | -$136.6M | -$218.6M | |
Other Financing Activities | -$1.7M | $3M | -$7.5M | -$1.7M | -$50.5M | |
Cash From Financing | -$42.4M | -$78.1M | -$183.9M | -$137.2M | -$263.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $56.3M | $98M | -$180M | -$27.4M | -$58.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $138M | $164.6M | $132.9M | $103.5M | $225.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.5M | $21.3M | -$12.1M | $8.6M | $40M | |
Depreciation & Amoritzation | $17.2M | $26.6M | $27.3M | $25.2M | $23.6M | |
Stock-Based Compensation | $7.2M | $9.5M | $25.2M | $27.3M | $17.1M | |
Change in Accounts Receivable | $47.2M | $92.7M | $164.1M | $158.1M | $163.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $77.4M | $74.9M | $42M | $14M | $62.3M | |
Capital Expenditures | $12M | $10.9M | $37.2M | $13.8M | $17.1M | |
Cash Acquisitions | -- | -- | -$6.5M | -$527K | -- | |
Cash From Investing | -$17M | $16.9M | -$36.1M | -$13.9M | -$17.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $78.5M | -- | -- | -- | |
Long-Term Debt Repaid | -$182K | -$78.5M | -- | -- | -- | |
Repurchase of Common Stock | -$4.9M | -$8.3M | -$51M | -$62.1M | -$56.2M | |
Other Financing Activities | -$378K | $6.7M | -$22.5M | -$432K | -$471K | |
Cash From Financing | -$3.4M | -$1.4M | -$72.2M | -$62.2M | -$54.8M | |
Beginning Cash (CF) | $488M | $515.5M | $448.2M | $411.3M | $290.9M | |
Foreign Exchange Rate Adjustment | -$24.9M | -$16.7M | -$1.2M | -$7.3M | $5.2M | |
Additions / Reductions | $56.9M | $90.5M | -$66.4M | -$62.1M | -$10M | |
Ending Cash (CF) | $520.1M | $589.3M | $380.7M | $341.9M | $286.2M | |
Levered Free Cash Flow | $65.4M | $64.1M | $4.8M | $173K | $45.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.